Reich, K., M. Lebwohl, C. Paul, M. Ropke, M. Rosen, and K. Hansen. “Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients With Moderate-to-Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S1, doi:10.25251/skin.2.supp.1.